59 related articles for article (PubMed ID: 3872870)
1. Dominant and recessive mitogen-nonproliferative variants of 3T3 cells.
Terwilliger E; Herschman HR
J Cell Physiol; 1985 Jun; 123(3):321-5. PubMed ID: 3872870
[TBL] [Abstract][Full Text] [Related]
2. Variants of 3T3 cells lacking mitogenic response to the tumor promoter tetradecanoyl-phorbol-acetate.
Butler-Gralla E; Herschman HR
J Cell Physiol; 1981 Apr; 107(1):59-67. PubMed ID: 6971296
[TBL] [Abstract][Full Text] [Related]
3. Phorbol diester and epidermal growth factor receptors in 12-O-tetradecanoylphorbol-13-acetate-resistant and -sensitive mouse epidermal cells.
Colburn NH; Gindhart TD; Hegamyer GA; Blumberg PM; Delclos KB; Magun BE; Lockyer J
Cancer Res; 1982 Aug; 42(8):3093-7. PubMed ID: 6284358
[TBL] [Abstract][Full Text] [Related]
4. Mitogenic effects of murine serum and fibroblast growth factor on EGF nonproliferative variants of 3T3.
Pruss RM; Herschman HR
J Supramol Struct; 1979; 12(4):467-70. PubMed ID: 317717
[TBL] [Abstract][Full Text] [Related]
5. Responses of preneoplastic epidermal cells to tumor promoters and growth factors: use of promoter-resistant variants for mechanism studies.
Colburn NH; Wendel E; Srinivas L
J Cell Biochem; 1982; 18(3):261-70. PubMed ID: 7068782
[TBL] [Abstract][Full Text] [Related]
6. Effects of retinoic acid on the binding and mitogenic activity of epidermal growth factor.
Jetten AM
J Cell Physiol; 1982 Mar; 110(3):235-40. PubMed ID: 6282898
[TBL] [Abstract][Full Text] [Related]
7. Variants of 3T3 cells lacking mitogenic response to epidermal growth factor.
Pruss RM; Herschman HR
Proc Natl Acad Sci U S A; 1977 Sep; 74(9):3918-21. PubMed ID: 302945
[TBL] [Abstract][Full Text] [Related]
8. Glucose uptake and ornithine decarboxylase activity in tetradecanoyl phorbol acetate non-proliferative variants.
Butler-Gralla E; Herschman HR
J Cell Physiol; 1983 Mar; 114(3):317-20. PubMed ID: 6833404
[TBL] [Abstract][Full Text] [Related]
9. Induction of tumor promotor-inducible genes in murine 3T3 cell lines and tetradecanoyl phorbol acetate-nonproliferative 3T3 variants can occur through protein kinase C-dependent and -independent pathways.
Lim RW; Varnum BC; O'Brien TG; Herschman HR
Mol Cell Biol; 1989 Apr; 9(4):1790-3. PubMed ID: 2471069
[TBL] [Abstract][Full Text] [Related]
10. Hexose uptake as an indicator of JB6 mouse epidermal cell resistance to the mitogenic activity of TPA.
Copley M; Gindhart T; Colburn N
J Cell Physiol; 1983 Feb; 114(2):173-8. PubMed ID: 6822609
[TBL] [Abstract][Full Text] [Related]
11. Intercellular heterogeneity of early mitogenic events: cAMP generalizes the EGF effect on c-Fos protein appearance but not on MAP kinase phosphorylation and nuclear translocation in dog thyroid epithelial cells.
Baptist M; Dumont JE; Roger PP
Exp Cell Res; 1995 Nov; 221(1):160-71. PubMed ID: 7589241
[TBL] [Abstract][Full Text] [Related]
12. Differential requirement of EGF receptor and its tyrosine kinase for AP-1 transactivation induced by EGF and TPA.
Li J; Ma C; Huang Y; Luo J; Huang C
Oncogene; 2003 Jan; 22(2):211-9. PubMed ID: 12527890
[TBL] [Abstract][Full Text] [Related]
13. Role of epidermal growth factor-stimulated protein kinase in control of proliferation of A431 cells.
Gill GN; Buss JE; Lazar CS; Lifshitz A; Cooper JA
J Cell Biochem; 1982; 19(3):249-57. PubMed ID: 6296169
[TBL] [Abstract][Full Text] [Related]
14. Effect of 12-O-tetradecanoylphorbol-13-acetate (TPA) on the growth inhibitory and increased phosphatidylinositol (PI) responses induced by epidermal growth factor (EGF) in A431 cells.
Smith KB; Losonczy I; Sahai A; Pannerselvam M; Fehnel P; Salomon DS
J Cell Physiol; 1983 Oct; 117(1):91-100. PubMed ID: 6311852
[TBL] [Abstract][Full Text] [Related]
15. Regulation by ceramide of epidermal growth factor signal transduction and mitogenesis in cell lines overexpressing the growth factor receptor.
Gallardo G; Tabraue C; Quintana J; López-Blanco F; Cabrera J; Díaz R; Estévez F; Ruiz de Galarreta CM; Fanjul LF; Santana P
Cell Mol Biol (Noisy-le-grand); 2000 Nov; 46(7):1305-12. PubMed ID: 11075960
[TBL] [Abstract][Full Text] [Related]
16. 3T3 variants unable to bind epidermal growth factor cannot complement in co-culture.
Terwilliger E; Herschman HR
Biochem Biophys Res Commun; 1984 Jan; 118(1):60-4. PubMed ID: 6320832
[TBL] [Abstract][Full Text] [Related]
17. Sarcoma growth factor (SGF): specific binding to epidermal growth factor (EGF) membrane receptors.
De Larco JE; Todaro GJ
J Cell Physiol; 1980 Feb; 102(2):267-77. PubMed ID: 6246130
[TBL] [Abstract][Full Text] [Related]
18. A 12-O-tetradecanoylphorbol-13-acetate (TPA)-nonproliferative variant of 3T3 cells is resistant to TPA-enhanced gene amplification.
Herschman HR
Mol Cell Biol; 1985 May; 5(5):1130-5. PubMed ID: 4000120
[TBL] [Abstract][Full Text] [Related]
19. Receptor-mediated effects on ligand availability influence relative mitogenic potencies of epidermal growth factor and transforming growth factor alpha.
Reddy CC; Wells A; Lauffenburger DA
J Cell Physiol; 1996 Mar; 166(3):512-22. PubMed ID: 8600155
[TBL] [Abstract][Full Text] [Related]
20. Engineering epidermal growth factor for enhanced mitogenic potency.
Reddy CC; Niyogi SK; Wells A; Wiley HS; Lauffenburger DA
Nat Biotechnol; 1996 Dec; 14(13):1696-9. PubMed ID: 9634854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
